Autres langues Windlas Biotech Limited

Actions

WINDLAS

INE0H5O01029

Marché Fermé - NSE India S.E. Autres places de cotation 13:40:31 11/06/2024			Varia. 5j.	Varia. 1 janv.
665 ^INR	+2,19%		+5,32%	+55,09%

20/05	Windlas Biotech Limited annonce ses résultats pour le quatrième trimestre clos le 31 mars 2024	CI
20/05	Windlas Biotech Limited publie ses résultats pour l'exercice clos le 31 mars 2024	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Windlas Biotech Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	20/05
Windlas Biotech Limited Reports Earnings Results for the Full Year Ended March 31, 2024	20/05
Windlas Biotech Commissions New Injectible Manufacturing Unit	02/04
Windlas Biotech Limited Commissions Its Injectable Facility	02/04
Windlas Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	08/02
Windlas Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	08/02
Windlas Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	08/11
Windlas Biotech Limited Approves Final Dividend for the Financial Year 2022-23	12/09/23
Windlas Biotech Limited Proposes Final Dividend for the Financial Year 2022-23	18/08/23
Windlas Biotech Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	08/08/23
Windlas Biotech's Consolidated Profit Slips in Fiscal Q4	08/05/23
Windlas Biotech Limited Reports Earnings Results for the Full Year Ended March 31, 2023	05/05/23
Windlas Biotech Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	05/05/23
Windlas Biotech Limited Recommends Dividend	05/05/23
Tranche Update on Windlas Biotech Limited's Equity Buyback Plan announced on November 8, 2022.	05/05/23
Tranche Update on Windlas Biotech Limited's Equity Buyback Plan announced on November 8, 2022.	03/05/23
Windlas Biotech Limited's Equity Buyback announced on November 8, 2022 has closed with 867,747 shares, representing 3.98% for INR 217.97 million.	03/05/23
Windlas Biotech's Consolidated Profit Climbs in Fiscal Q3	09/02/23
Windlas Biotech Limited Appoints Komal Gupta as the Chief Executive Officer	09/02/23
Windlas Biotech Appoints CEO	09/02/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Windlas Biotech Limited

Actions

WINDLAS

INE0H5O01029

Autres langues

Filtres